Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'celgene corporation - financial and strategic analysis review' returned 6 results - Page 1 of 1   Sort by    Report Name ASC Report Name DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Novartis: Performance - Products - Pipeline - Potential   Espicom Business Intelligence Ltd, Aug 2008, Pages: 226 ... The company's financial performance is covered in ... A section on company strategy covers mergers ... Pharma - Biovail Corporation - Celgene Corporation - Cell Genesys ... The Fastest Growing Biotechnology Companies: Growth Strategies, Comparative Analyses and Company Profiles   Business Insights, March 2008, Pages: 280 ... address and contact details 135 Company overview and ... 138 Source and details of income 138 Review of ... 143 Opportunities 144 Acquisition by Celgene 144 Inorganic ... Merck KGaA: Pipeline, Products, Performance and Potential   Espicom Business Intelligence Ltd, June 2009, Pages: 144 ... Segment Performance - Company Strategy - Mergers, Acquisitions ... APPENDIX 1 - FINANCIAL PERFORMANCE - Full ... Myers Squibb - Celgene Corporation - Cellular Genomics ... Small Molecule Kinase Inhibitors - Global Strategic Business Report   Global Industry Analysts, Inc., July 2009, Pages: 558 ... MOLECULE KINASE INHIBITORS A GLOBAL STRATEGIC BUSINESS REPORT ... Effective Antidotes II-9 Financial-based Contracts ... Company (US) II-64 Celgene Corporation (US) II ... UK IFAs 2007   Datamonitor, Oct 2007, Pages: 91 ... market have been particularly strategic 64 AXA ... distribution channels 84 Independent Financial Advisors (IFAs ... Groupe Celera Genomics Celgene Corporation CEL-SCI ... Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues   Just Pharma Reports, April 2008, Pages: 105 ... as a stimulus to get the company started. ... biopharmaceutical manufacturers, legal and financial firms ... Biocodex Bioenvision BioMarin BMS Celgene Cell Therapeutics ... No more results

		Top of page

All rights reserved. © Copyright 2009 Research and Markets0    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster